Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As Rousseff Impeachment Looms Could Her Successor Help Pharma In Brazil?

Executive Summary

Brazil is not an easy place to do business at the moment. Its economy is in deep recession, its political class is mired in a far-reaching corruption scandal and now it looks increasingly likely that President Dilma Rousseff will be impeached for fiddling the figures to make the fiscal deficit look better. "But from the very bottom, the only place to go is up," says Benny Spiewak, from the Brazilian law firm Zancaner Costa, Bastos and Spiewak. He thinks a new leader could do much for pharmaceutical R&D and restore relations with an embattled industry.

Advertisement

Related Content

Brazil, Mexico Taking Divergent Paths On Regulatory Reform
Brazilian Notebook: Key Themes From BIO Latin America

Topics

Advertisement
UsernamePublicRestriction

Register

SC065024

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel